Newer Drugs Beat Gleevec in Head-to-Head Trials
More chronic myeloid leukemia patients responded to Sprycel and Tasigna than GleevecContinue Reading
More chronic myeloid leukemia patients responded to Sprycel and Tasigna than GleevecContinue Reading
Studies show combo chemotherapy, new drug prolonged lives of some with advanced diseaseContinue Reading
First in its class, ipilimumab showed 68% increase in survival, researchers reportContinue Reading
Lower rates of complications, death in elderly who don’t delay surgery, research showsContinue Reading
Traits date back several millennia and may help trace inherited links to many diseases, researchers sayContinue Reading
Technology helped researchers analyze bone fragments to rule out one of many theoriesContinue Reading
Three common techniques all deemed safe, but one appeared safest, research showsContinue Reading
But combined techniques less likely to be used for those at highest risk, study findsContinue Reading
Researchers believe canines have a role to play in disease detectionContinue Reading
© 2021 TheHealthCast.com - All Rights Reserved.